Other Viruses Citation List:
November 25 - December 8, 2011
Hepatitis B Virus
1. Lignans with anti-Hepatitis B Virus Activities from Phyllanthus niruri L. Wei, W., X. Li, K. Wang, Z. Zheng, and M. Zhou, Phytotherapy Research : PTR, 2011. [Epub ahead of print]; PMID[22131154].
[Pubmed]. OV_1125-120811.
2. In Vitro anti-Hepatitis B and SARS Virus Activities of a Titanium-substituted-heteropolytungstate. Qi, Y.F., H. Zhang, J. Wang, Y. Jiang, J. Li, Y. Yuan, S. Zhang, K. Xu, Y. Li, J. Niu, and E. Wang, Antiviral Research, 2011. [Epub ahead of print]; PMID[22127069].
[Pubmed]. OV_1125-120811.
Hepatitis C Virus
3. 3-Heterocyclyl Quinolone Inhibitors of the HCV NS5B Polymerase. Kumar, D.V., R. Rai, K.A. Brameld, J. Riggs, J.R. Somoza, R. Rajagopalan, J.W. Janc, Y.M. Xia, T.L. Ton, H. Hu, I. Lehoux, J.D. Ho, W.B. Young, B. Hart, and M.J. Green, Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[22119470].
[Pubmed]. OV_1125-120811.
4. Self-assembling Peptide Nanotubes with Antiviral Activity against Hepatitis C Virus. Montero, A., P. Gastaminza, M. Law, G. Cheng, F.V. Chisari, and M.R. Ghadiri, Chemistry & Biology, 2011. 18(11): p. 1453-1462; PMID[22118679].
[Pubmed]. OV_1125-120811.
5. (-)-Epigallocatechin-3-gallate is a New Inhibitor of Hepatitis C Virus Entry. Calland, N., A. Albecka, S. Belouzard, C. Wychowski, G. Duverlie, V. Descamps, D. Hober, J. Dubuisson, Y. Rouille, and K. Seron, Hepatology (Baltimore, Md.), 2011. [Epub ahead of print]; PMID[22105803].
[Pubmed]. OV_1125-120811.
6. Novel HCV NS5B Polymerase Inhibitors: Discovery of Indole C2 acyl sulfonamides. Anilkumar, G.N., O. Selyutin, S.B. Rosenblum, Q. Zeng, Y. Jiang, T.Y. Chan, H. Pu, L. Wang, F. Bennett, K.X. Chen, C.A. Lesburg, J. Duca, S. Gavalas, Y. Huang, P. Pinto, M. Sannigrahi, F. Velazquez, S. Venkatraman, B. Vibulbhan, S. Agrawal, E. Ferrari, C.K. Jiang, H.C. Huang, N.Y. Shih, F. George Njoroge, and J.A. Kozlowski, Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[22104146].
[Pubmed]. OV_1125-120811.
Human Cytomegalovirus
7. Capilloquinol: A Novel Farnesyl Quinol from the Dongsha Atoll Soft Coral Sinularia capillosa. Cheng, S.Y., K.J. Huang, S.K. Wang, and C.Y. Duh, Marine Drugs, 2011. 9(9): p. 1469-1476; PMID[22131951].
[Pubmed]. OV_1125-120811.
Citations from the ISI Web of Knowledge Listings for O.V.
8. Hepatitis C Virus Nucleotide Inhibitors PSI-352938 and PSI-353661 Exhibit a Novel Mechanism of Resistance Requiring Multiple Mutations within Replicon RNA. Lam, A.M., C. Espiritu, S. Bansal, H.M.M. Steuer, V. Zennou, M.J. Otto, and P.A. Furman, Journal of Virology, 2011. 85(23): p. 12334-12342; ISI[000296708100022].
[WOS]. OV_1125-120811.
9. Synthesis and Antiviral Activity of 2 '-Deoxy-2 '-fluoro-2 '-C-methyl-7-deazapurine nucleosides, Their Phosphoramidate Prodrugs and 5 '-Triphosphates. Shi, J.X., L.H. Zhou, H.W. Zhang, T.R. McBrayer, M.A. Detorio, M. Johns, L. Bassit, M.H. Powdrill, T. Whitaker, S.J. Coats, M. Gotte, and R.F. Schinazi, Bioorganic & Medicinal Chemistry Letters, 2011. 21(23): p. 7094-7098; ISI[000296717600034].
[WOS]. OV_1125-120811.
10. A New Method for Induced Fit Docking (GENIUS) and Its Application to Virtual Screening of Novel HCV NS3-4A Protease Inhibitors. Takaya, D., A. Yamashita, K. Kamijo, J. Gomi, M. Ito, S. Maekawa, N. Enomoto, N. Sakamoto, Y. Watanabe, R. Arai, H. Umeyama, T. Honma, T. Matsumoto, and S. Yokoyama, Bioorganic & Medicinal Chemistry, 2011. 19(22): p. 6892-6905; ISI[000296535900040].
[WOS]. OV_1125-120811.
11. Expression of an IRF-3 Fusion Protein and Mouse Estrogen Receptor, Inhibits hepatitis C Viral Replication in RIG-I-deficient Huh 7.5 Cells. Yao, L.Y., X.B. Yan, H.J. Dong, D.R. Nelson, C. Liu, and X.Y. Li, Virology Journal, 2011. 8: p. 445; ISI[000296867400001].
[WOS]. OV_1125-120811.